Overview

Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.

Status:
Completed
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
This study was designed to assess the bioequivalence of Olanzapine tablets of two different manufacturers and to investigate the safety and tolerability of Olanzapine tablets of two different manufacturers.
Phase:
Phase 1
Details
Lead Sponsor:
Joint Stock Company "Farmak"
Treatments:
Olanzapine